UTEC has returned to co-lead a $14m funding round for ImmunoScape, which will use the money to bolster its presence in Singapore and the US.

ImmunoScape, a Singapore-based immunonics platform developer spun out of the Agency for Science, Technology and Research (A*Star), pocketed $14m in a funding round co-led by University of Tokyo Edge Capital Partners (UTEC) yesterday. Anzu Partners and EDBI, the investment arm of the Economic Development Board of Singapore, co-led the round. ImmunoScape is working on a…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.